tiprankstipranks
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
US Market
BDRX
Biodexa Pharmaceuticals
RESEARCH TOOLSreports

Biodexa Pharmaceuticals (BDRX) Cash flow

538 Followers

Biodexa Pharmaceuticals Cash Flow

BDRX's free cash flow for Q4 2025 was £-2.33M. For the 2025 fiscal year, BDRX's free cash flow was decreased by £7.64M and operating cash flow was £-2.33M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
£ -5.39M£ -12.26M£ -6.83M£ -7.05M£ -6.01M
Investing Cash Flow
£ -658.25K£ -598.00K£ -265.00K£ -220.00K£ -278.00K
Financing Cash Flow
£ 12.77M£ 8.56M£ 10.23M£ 47.00K£ 8.80M
End Cash Position
£ 8.52M£ 1.67M£ 5.97M£ 2.84M£ 10.06M
Free Cash Flow
£ -5.40M£ -13.04M£ -7.09M£ -7.11M£ -6.33M
Currency in GBP

Biodexa Pharmaceuticals Cash Flow